Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1045 studies found for:    "Follicular lymphoma"
Show Display Options
Rank Status Study
1 Terminated
Has Results
Trial of Low-Dose Methotrexate and I 131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma
Condition: Follicular Lymphoma
Interventions: Drug: Bexxar;   Drug: Low Dose Methotrexate
2 Completed High-Dose Therapy Treatment in Patients With Follicular Lymphoma
Condition: Follicular Lymphoma
Interventions: Procedure: chemotherapy;   Procedure: high dose therapy and autologous stem cell transplantation
3 Terminated Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma
Condition: Follicular Lymphoma
Interventions: Drug: IPI-145 (duvelisib);   Drug: Placebo;   Drug: Rituximab
4 Unknown  Multicentric Study, Three Randomized Arms (R−CVP vs R−CHOP vs R−FM),for Patients With Stage II−IV Follicular Lymphoma
Condition: Follicular Lymphoma
Interventions: Drug: R-CVP;   Drug: R-CHOP;   Drug: R-FM
5 Not yet recruiting An Open-Label, Randomized Study Comparing INCB050465 to Idelalisib in Relapsed or Refractory Follicular Lymphoma (CITADEL-203)
Condition: Follicular Lymphoma
Interventions: Drug: INCB050465;   Drug: Idelalisib
6 Completed Randomized Study for Patients With Follicular Lymphoma Needing Treatment
Condition: Follicular Lymphoma
Interventions: Procedure: CHVP + interferon;   Drug: fludarabine;   Procedure: CHOP + TBI and autotransplant
7 Active, not recruiting Lenalidomide and Idelalisib in Treating Patients With Recurrent Follicular Lymphoma
Condition: Recurrent Follicular Lymphoma
Interventions: Drug: idelalisib;   Drug: lenalidomide
8 Completed CD180 Overexpression in Follicular Lymphoma
Condition: Follicular Lymphoma
Intervention:
9 Recruiting Bendamustine in Combination With Rituximab as a First-line Therapy Followed by Maintenance Therapy With Rituximab in Patients With Follicular Lymphoma
Condition: Follicular Lymphoma
Intervention: Drug: Rituximab, bendamustine
10 Recruiting Rituximab With or Without Ibrutinib for Patients With Advanced Follicular Lymphoma
Condition: Follicular Lymphoma
Interventions: Drug: Ibrutinib;   Drug: Rituximab
11 Unknown  Dietary Intervention in Follicular Lymphoma
Condition: Follicular Lymphoma
Interventions: Drug: Omega 3 fatty acids (EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid));   Drug: Selenium (L-Selenomethionine),;   Drug: Garlic extract (Allicin);   Drug: Pomegranate juice (ellagic acid);   Drug: Grape juice (resveratrol, quercetin);   Drug: Green Tea (Epigallocathechin gallate)
12 Active, not recruiting Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma
Condition: Follicular Lymphoma
Interventions: Drug: Rituximab;   Drug: Lenalidomide;   Drug: Rituximab-CHOP;   Drug: Rituximab-CVP;   Drug: Rituximab-Bendamustine
13 Recruiting A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06)
Condition: Follicular Lymphoma
Interventions: Biological: PF-05280586;   Biological: MabThera®
14 Completed Immunochemotherapy, Zevalin, and Bone Marrow Transplant for Follicular Lymphoma
Condition: Follicular Lymphoma
Intervention: Other: Combination of treatment modalities
15 Unknown  Zevalin® First Line in Follicular Lymphoma
Condition: Follicular Lymphoma
Interventions: Drug: 90Yttrium-Ibritumomab Tiuxetan (Zevalin®)+Rituximab;   Drug: Rituximab
16 Active, not recruiting Radiotherapy Versus Radiotherapy Plus Chemotherapy in Early Stage Follicular Lymphoma
Condition: Follicular Lymphoma
Interventions: Drug: Cyclophosphamide;   Radiation: Radiotherapy;   Drug: Vincristine;   Drug: Prednisolone;   Drug: Rituximab
17 Active, not recruiting A Phase 3 Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma
Condition: Follicular Lymphoma
Interventions: Drug: Rituximab;   Drug: Lenalidomide;   Drug: Rituximab - CHOP;   Drug: Rituximab - CVP;   Drug: Rituximab - Bendamustine
18 Recruiting Study of Obinutuzumab and Lenalidomide in Previously Untreated Subjects With Follicular Lymphoma
Condition: Follicular Lymphoma
Interventions: Drug: Obinutuzumab;   Drug: Lenalidomide
19 Recruiting Obinutuzumab in Combination With Venetoclax in Previously Untreated Follicular Lymphoma Patients
Condition: Follicular Lymphoma
Interventions: Drug: Obinutuzumab;   Drug: Venetoclax
20 Unknown  A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients
Condition: Follicular Lymphoma
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Vincristine;   Drug: Prednisolone;   Drug: Fludarabine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.